Cision PR Newswire

PHILADELPHIA, July 20, 2022 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Convey Health Solutions Holdings, Inc. ("Convey Health") (NYSE: CNVY) on behalf of the company's investors.

On June 21, 2022, Convey Health announced that it had agreed to be acquired by private equity firm TPG at a price of $10.50 per share. Following the closing of the proposed transaction, CNVY's shareholders will be cashed out of their investment position, and the company's shares will no longer be publicly traded.

The investigation seeks to determine (i) whether Convey Health shareholders will be receiving sufficient monetary consideration for their shares, and (ii) whether Convey Health's directors breached their fiduciary duties to CNVY stockholders in agreeing to sell the company to TPG.

Convey Health shareholders who wish to receive additional information about this investigation and their legal rights and options are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (888) 715 – 1740, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/convey-health/ .

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation, and has helped recover in excess of $100 million on behalf of victimized investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. 

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
(888) 715 – 1740
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cnvy-shareholder-alert-kaskela-law-llc-investigates-fairness-of-10-50-per-share-buyout-price-301589674.html

SOURCE Kaskela Law LLC